How the Skin's Natural Antimicrobial Peptides Play a Key Role in Acne and Could Lead to New Treatments | Research

The takeaway

A review identifies antimicrobial peptides like LL-37 and β-defensins as key regulators of acne development, acting as compensatory skin barrier protectors and potential therapeutic agents.

AMPs elevated as compensatory mechanism
Antimicrobial peptides like LL-37 and β-defensins rise in acne skin to protect a compromised barrier, linking immune defense to metabolic pathways like insulin/IGF-1 and PI3K/Akt/mTOR

What the researchers found

The review identifies several key roles of antimicrobial peptides in acne:

- AMPs (human β-defensins, cathelicidin LL-37, dermcidin, RNase-7) are elevated in acne-affected skin

- They function as both antibacterial agents and immune modulators, coordinating host-microbiota interactions

- AMPs improve skin tight junction (TJ) barrier function by activating PI3K, GSK-3, aPKC, and Rac1 proteins

- Elevated AMP expression likely represents a compensatory mechanism to protect skin with impaired permeability

- AMPs link acne immune responses to metabolic signaling (insulin/IGF-1, PI3K/Akt/mTOR/FoxO1, glucotoxicity)

- Acne is associated with decreased diversity of C. acnes phylotypes, with AMPs potentially regulating this dysbiosis

Why it matters

Antibiotic-resistant acne is a growing problem, and current treatments have significant side effects. Understanding how the skin's own antimicrobial peptides regulate acne could lead to entirely new treatment approaches that work with the body's natural defense systems rather than against bacteria directly. AMP-based therapies could potentially avoid the antibiotic resistance problem.

How the study worked

This is a comprehensive literature review incorporating recent transcriptomic studies, examining the role of antimicrobial peptides in acne pathogenesis. The review covers AMP expression patterns, their mechanisms of action in skin barrier maintenance and immune regulation, and the current state of AMP-based therapeutic development for acne.

What this study cannot tell us

As a review article, no original data is presented. The hypothesis that AMPs act primarily as compensatory barrier protectors in acne is intriguing but requires further experimental validation. The complexity of acne pathogenesis (hormonal, genetic, microbial, immune) makes it difficult to isolate the specific contribution of AMPs. AMP-based acne therapeutics are still in early development stages.

How to read the evidence

This is a narrative review incorporating recent transcriptomic data and published research. It provides a compelling mechanistic framework but relies on synthesizing existing evidence rather than presenting new experimental results.

When this study was published

Published in 2024, this review incorporates the latest transcriptomic and molecular insights into the role of antimicrobial peptides in acne pathogenesis.

The bigger picture

Antimicrobial peptide research is a rapidly growing field with applications across dermatology, infectious disease, and wound healing. This review specifically connects AMP biology to one of the most common skin conditions worldwide — acne — and highlights how metabolic factors (insulin, mTOR) intersect with innate immune peptide responses. The growing problem of antibiotic resistance makes AMP-based alternatives increasingly attractive.

Questions still open

Could topical AMP formulations provide effective acne treatment without promoting antibiotic resistance?
Do dietary and hormonal factors that worsen acne act partly through modulation of skin AMP expression?
Would personalized acne treatment based on a patient's AMP expression profile be more effective than current approaches?

Common questions

What are antimicrobial peptides and how do they relate to acne?

Antimicrobial peptides are natural molecules your skin produces to fight bacteria and regulate immune responses. In acne, the skin produces more of these peptides — like LL-37 and β-defensins — as a defense mechanism. They help protect the compromised skin barrier and fight acne-causing bacteria.

Could antimicrobial peptides replace antibiotics for treating acne?

Potentially. Unlike antibiotics, AMPs work through multiple mechanisms making resistance less likely. Researchers are developing AMP-based treatments that could kill acne bacteria, reduce inflammation, and repair the skin barrier simultaneously — offering advantages over traditional antibiotics.

Read the original research

Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris.

Frontiers in immunology, 15, 1502242

View on PubMed ↗Publisher’s paper ↗

Citation

Lesiak, Agata; Paprocka, Paulina; Wnorowska, Urszula; Mańkowska, Angelika; Król, Grzegorz; Głuszek, Katarzyna; Piktel, Ewelina; Spałek, Jakub; Okła, Sławomir; Fiedoruk, Krzysztof; Durnaś, Bonita; Bucki, Robert. (2024). Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris.. Frontiers in immunology, 15, 1502242. https://doi.org/10.3389/fimmu.2024.1502242